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abstract 
Objectives: China has very high rates of antibiotic resistance and a health care system that provides strong incentives for over-prescribing. This paper 
describes the findings of a qualitative study in a province of southern China that seeks to assess knowledge, attitudes, and practices in relation to the 
use of antibiotics. 
 
Methods: Semi-structured interviews with patients and health workers at provincial, county, township, and village level. Interviews used four probes 
(common cold, cough, mild diarrhoea and tiredness) where antibiotics were not indicated, supplemented by questions on knowledge, attitudes, and 
practices. These data were supplemented by two focus groups, with medical students and pharmacists, and discussions with participants at a national 
conference on antibiotic use. 
 
Results: Coughs and diarrhoea are almost universally treated with antibiotics, while the cold is normally treated with antivirals instead or as well. 
Many physicians are aware that the cold is usually self-limiting but believe that they can speed recovery and that they are responding to patient 
expectations. Most physicians and many patients are aware of the phenomenon of antibiotic resistance, although it is often seen as a property acquired 
by the patient and not the micro-organism. Physicians face financial incentives to prescribe, with profit splitting with pharmaceutical suppliers. Sales 
profits form a major part of a hospital’s income. National guidance on use of antibiotics is fragmentary and incomplete. 
 
Conclusion: The misuse of antibiotics poses considerable risks. Effective action will require a multi-faceted strategy including education, based on an 
understanding of existing beliefs, the replacement of perverse incentives with those promoting best practice, and investment in improved surveillance. 
Much of this will require action at national level. 
 
 
 
1. Introduction 
Rates of antibiotic resistance in China are growing rapidly from already high levels [1–4]. At least part of the explanation lies in 
changes in the health system over the past two decades. The health system that China established in the 1950s was a remarkable 
improvement on what had existed previously. Medical training and hospital construction increased greatly, while effective 
campaigns were conducted against endemic diseases such as schistosomiasis and malaria. Primary health care provision in 
rural areas was boosted by the introduction of “barefoot doctors”. These changes made it possible for 90% of the population to 
access at least basic care [5] and contributed to China’s marked improvement in life expectancy in the three decades following the 
Communist takeover, from 35 years in 1949 to 68 years in 1981 [6]. Nevertheless, by 1981, healthcare accounted for only 3% of a 
comparatively low GDP [7]. 
 
During the reforms instituted by Deng Xiaoping in the early 1980s, the health system deteriorated, suffering from low salaries and a 
lack of investment [8]. The introduction of “market socialism” in all aspects of public life led to further reductions in resources. A 
new system, introduced in the early 1990s [9], limited state financing to about 25–30% of total costs [10], covering only the basic 
costs of salaries and facilities. Staff were to supplement their income from bonus schemes, funded from sales profits on drugs, tests 
and services [9] with staff fined for missing sales quotas [11]. Medical insurance covered those employed in state enterprises, but 
with a decreasing proportion of the population in such employment, by 2005 only 25% of people living in urban areas [12] and 10% 
of rural Chinese had any cover [7]. Costs of insurance schemes escalated, as prices rose to cover profit-loading by providers, and 
over-prescription escalated claims [13], so cost-sharing and claims ceilings were introduced to limit expenditure [9]. 
 
Studies carried out in the late 1990s provided evidence that fee-for-service provision, provider bonuses, and medical insurance all 
encouraged prescription of more items, more expensive medications, and newer antibiotics [5,14–16]. The result was that per 
capita consumption of medicines increased almost fourfold between 1979 and 1992 [8]. By the mid-1990s, more than half of 
hospital spending was on pharmaceuticals [5,7,10,17], with one survey in 1990 finding that each visit to a physician led to the 
prescription, on average, of 2.3 drugs [18] while another, among villages in western China found that about half of all prescriptions 
were for antibiotics [19]. Liu and Mills reported over-prescribing (expressed as cost of drugs) of 38% for pneumonia and 34% for 
appendicitis in six public hospitals in the period 1987–1997 [20], while Meng et al. [21], in a 2000 study in 109 village clinics in 
Shandong province, found over-treatment (again by cost) of 60%. A study reported in 2005, from Beijing found overuse of broad-
spectrum antibiotics, especially the most expensive [22]. Interviews and focus groups attributed this to the policy of requiring 
hospitals to support themselves from profits, gaps in the knowledge of junior staff coupled with a tendency to rely on information 
from pharmaceutical companies, and concern about possible litigation. 
 
A key issue is the prescription of antibiotics when they are not indicated. A study in Wuhan found that bacteriology samples were 
rarely taken before antibiotics were prescribed [23] In these circumstances, it is unsurprising that a 2006 study concluded that the 
problem was due, primarily, to “the over-the-counter purchase and community use of fluoroquinolines in the People’s Republic of 
China” [24]. 
 
While the scale and nature of the problem are apparent, there is rather less research on how the system shapes decisions made by 
patients and physicians in their everyday encounters. This information will be essential if effective policies are to be put in place. In 
this paper, we report a qualitative investigation of the determinants of prescribing for common conditions in one province of 
southern China. 
 
2. Methods 
The research was set in Guizhou, a landlocked province in southern China, bordered by Sichuan to the north, Yunnan to the west, 
Guangxi to the south and Hunan to the east. Much of the province is mountainous, with forestry and coal mining dominating the 
economy. Almost 40% of the population are from China’s minority ethnic groups. This study was part of a larger one looking at the 
entire range of iatrogenic factors that might play a role in transmission of blood-borne viruses. The other elements will be described 
elsewhere [25]. 
 
The approach was based on grounded theory, whereby themes emerge from initial analyses which are then explored in an iterative 
manner through purposive sampling of relevant key informants and triangulation with other sources of data [26].  The main source 
of data was a series of semi-structured interviews conducted in rural and urban Guizhou with a purposive sample of healthcare 
staff, patients, and other key informants, including civil representatives, at provincial, county, and village facilities. Three villages 
were selected, in consultation with the provincial staff of the Chinese Centres for Disease Control (CDC), with the goal of including 
ones with different levels of economic development. 
 
Patients were identified by convenience sampling from those present in the health facility on the selected days. The health workers 
interviewed were, at village level, doctors, and at township, county and provincial level, the hospital director, surgeon/ obstetrician, 
and officials in charge of safety and procurement. Additional key informants included village leaders, family planning officials, 
and state and independent pharmacists. 
 
The interview framework was structured around four different minor tracer complaints, common cold, cough, mild diarrhoea and 
tiredness, chosen as ailments that would rarely merit any medical intervention if rational treatment principles were followed. 
Follow up questions pursued points raised by interviewees about influences on prescription choices. The interviews were all carried 
out by LR, in the presence of a local research assistant who was fluent in the local dialect. Immediately after each interview, both 
checked transcripts together to resolve any ambiguities. The transcriptions were then read and analysed by both authors to identify 
emerging themes. These themes were then explored in more detail with key informants with knowledge of the Chinese health 
system and in two focus groups. One comprised university students, addressing the impact of pharmaceutical advertising, and the 
other comprised pharmacists in the Guizhou provincial hospital, to explore procedural and legal constraints on prescribing. In both 
cases a list of relevant topics was derived from the interviews and participants were presented with corresponding scenarios. LR led 
the focus groups, which were then transcribed by a research assistant. Less formal individual and group interviews were conducted 
with clinicians and researchers at the December 2005 Second National Conference on Rational Use of Antibiotics in Beijing. This was 
designed to provide some idea of whether the findings obtained were exceptional in China or whether they could, with caution, be 
generalised. 
 
Ethical approval was granted by the relevant committees of the Chinese Ministry of Health and the London 
School of Hygiene and Tropical Medicine. 
 
3. Results 
The initial sample comprise d 24 patients (15 rural, 9 urban), 11 village doctors, health workers at higher levels of the system 
(township hospital, 4; county hospital, 7; provincial hospital, 15), two independent pharmacists, 2 village leaders, and 3 family 
planning officials. Subsequent interviews, to clarify emerging themes, were conducted with two other doctors in the state system, 
two in the private sector, and two in non-governmental organisations, as well as three from the Centre for Disease Control and 
three 3 foreign health workers. The last group comprised North Americans who had been working with different non-governmental 
organisations in China for bet ween 12 and 20 years and who therefore were i n a position to provide an international perspective. 
 
3.1. Antibiotic treatment by clinicians  
Healthcare workers and key informants reported that antibiotics are not only used incorrectly for susceptible bacterial infections, 
but also frequently for problems known not to have bacterial aetiology. Those suffering from any complaint other than tiredness 
routinely received antibiotic treatment. Many, but not all healthcare workers, were aware that a cold is a self-limiting viral infection, 
but most treated it with antivirals (ribavirin, acyclovir or moroxydine), antibiotics, or both, sometimes combined with symptomatic 
treatments and Traditional Chinese Medicines (TCM). Because colds are self-resolving, the healthcare worker who treats them 
benefits from a n apparently successful cure, promoting recommendations by patients and leading to a cycle of over-treatment. 
Some prescribers did disapprove of using antibiotics for colds; one outpatient doctor reported refusing to prescribe them 
unless pressurise d by patients. Coughs were also treated with antibiotics at all levels of the system. 
 For mild diarrhoea, quinolines and sulphonamides are prescribed. At the provincial hospital, treatment is usually with intravenous 
(IV) antibiotics selected according to the results of stool tests when available, but sometimes blindly. 
 
3.2. Perceptions of antibiotic resistance 
Awareness of the phenomenon of antibiotic resistance was generally high, even if not always fully understood. A doctor in the 
county hospital reported that penicillin work s less well for city people than for villagers, whose access to care is limited by their low 
incomes, indicating an understanding that its development was linked to previous use. Both healthcare workers and patients had 
notice d that antibiotics were gradually becoming less effective. However, this was of ten attributed to the patient developing 
resistance rather than the micro-organism. One patient observe d that “if you take injections and infusions easily, you can damage 
your immunity and will become resistant to medicine”. An older hospital pharmacist commented  
“antibiotic dosages have risen greatly. This is because people have some substance in their bodies which can resist the 
drug; if they can be treated by one pill the first time, the second time it takes two pills and the third time three pills.” 
 
3.3. Initiatives to reduce misuse of antibiotics 
Diagnosis is most often based on symptoms. Laboratory confirmation and testing for antibiotic sensitivity are rare, reflecting both 
lack of access to laboratory facilities in villages and affordability in cities. Clinicians typically try different antibiotics until symptoms 
cease. 
 
Many doctors interviewed expressed concern about the potential ill effects of antibiotic use; yet most, by their own accounts, 
considerably over-prescribed. Their concern was mainly to avoid long courses, to which they attributed toxicity, damage to 
microflora and the development of resistance. No respondent mentioned inappropriate use of broad-spectrum or unsuitable 
antibiotics. Few were aware that courses that were too short might facilitate the emergence of resistant strains. 
 
In autumn 2004, a nationwide guideline was issued to hospitals, designating three classes of antibiotics based on clinical and safety 
profiles, with different rules for prescribing each class [27]. As explained by a provincial hospital doctor “Ordinary doctors in the 
hospital can prescribe the common antibiotics such as penicillin, but for the higher level antibiotics, they must seek permission from 
their head of department. For the new and expensive antibiotics, as we are not yet sure of the clinical implications, they must 
consult the specialists.” 
 
Younger doctors seemed more likely to start with the newest antibiotics, for profit or to demonstrate swift effect, but most follow 
the guidance to start with penicillin, despite widespread beta-lactam resistance. This leads to the inappropriate use of high dosages, 
in the hope of observing some effect. A pharmacist commented: “In the 1960s, the highest dosage of penicillin was 400,000 i.u., but 
now it is up to 800,000–1,200,000 i.u. In the past a cure required four shots, but now six to eight are needed.” While penicillin is 
relatively non-toxic at high doses, the idea of increasing dosages is carried across to other antibiotics where the hazards are greater. 
In this way, well-intentioned official guidance may be having perverse effects. 
 
3.4. Economic influences on antibiotic prescription: customers and suppliers 
Health workers recognised the financial incentives to prescribe as taking two forms. One was created by pharmaceutical companies, 
who sometimes arrange to split profits with prescribers, illegally and covertly, while the other emanated from all health providers, 
which are entitled to make a 15% profit on sales to fund services, but often inflate invoices to suppliers to increase the absolute 
profit. Some doctors did deplore the phenomenon of profit-led prescription but it was generally accepted as inevitable. It was noted 
that patients want their symptoms alleviated as quickly as possible, while minimising the fees they pay. Healthcare workers aim to 
maximise these fees, but share patients’ interest in fast treatment, since this attracts and retains patients. One consequence of this 
dynamic is over-prescription of antibiotics, especially the newest ones. Another is the prescription of only enough antibiotics to 
clear the patient’s symptoms, since the patient does not comprehend the benefit of paying for the rest of the course. 
 
Doctors and researchers attending the conference on antibiotic use confirmed the barriers to rational prescribing imposed by 
current hospital funding arrangements, which rely on maximising drug sales profits. They asserted that a shift to rational 
prescribing would destroy the revenue base of hospitals, further degrading service quality because of the cost-cutting necessary to 
break even without the income earned from irrational use of medication. 
 
3.5. Use of over-the-counter antibiotics 
Patients have acquired the habit of self-medication. A County Hospital outpatient doctor explained:  
“Many patients abuse antibiotics before they come to hospital, and have already developed drug resistance before they 
arrive. Thus each antibiotic course is 3 days, but the overall treatment is usually of longer duration.” 
 
He attributed this behaviour to promotion of antibiotics in the media. The focus group with medical students, when asked to identify 
the three most heavily advertised home remedies for diarrhoea, identified cotrimoxazole, norfloxacin and a locally made TCM 
remedy. Rural interviewees mentioned purchase of over-the-counter norfloxacin, furazolidine and cotrimoxazole for diarrhoea, and 
sulphanilamide to treat colds. Maintaining home stocks of antibiotics for family use is reportedly normal, as is taking antibiotics for 
diarrhoea several times a year. 
 
On 1 July 2004, the State Food and Drug Administration announced that pharmacies would no longer sell antibiotics without a 
prescription [28]. Interviews and observation at two pharmacies (one large and one small) indicated that the letter of the law was 
observed. However, the law’s spirit can be circumvented; staff at the large pharmacy explained that a doctor works there every 
morning who can prescribe as required. A researcher interviewed at the national conference confirmed the ubiquity of this 
practice and commented that the patient need not even be present at the pharmacy. 
 
3.6. Sources of guidance on antibiotic prescription  
Healthcare workers were asked what authorities they consult in decisions about prescribing. Existing guidance on antibiotic use 
appears to be profuse but inadequate. Clinicians referred to the frequency with which national guidance was issued, with no single 
authoritative documentary source available. No actual clinical guidelines could be identified at any level of the system, from the 
village to the provincial hospital. 
 
Some of the misconceptions about antibiotic use encountered were widely shared. A possible mechanism for their propagation and 
reinforcement is the acquisition of incorrect knowledge in teaching hospitals, which is then disseminated more widely. One doctor 
mentioned the Ministry of Health website (http://www.moh.gov.cn) as a source of clinical guidance on antibiotic use; this stated  
“70% of prescriptions are for antibiotics; China is now one of the heaviest users in the world. Among China’s 5 million 
tuberculosis patients, at least a quarter carry bacteria resistant to at least one antibiotic. Now people have realised the 
danger of antibiotic abuse. As a result we should strengthen rational prescription to stop antibiotic abuse, to reduce the 
side-effects and the costs caused by irrational prescription.. . . misuse will cause drug resistance”. 
 
However, this website gives no explanation about how to decide when to stop antibiotic courses, what rational prescription of 
antibiotics requires, or what “misuse” entails. 
 
When infections fail to resolve, patients are typically prescribed a further course but of different antibiotics. Thus, a single infection 
will often lead to multiple 3-day courses of different antimicrobials, often commencing with over the counter treatments. Well-
intended but unclear government publicity about antibiotic abuse may have increased the frequency of prescriptions for short 
courses of antibiotics, exacerbating resistance. 
 
4. Discussion 
This study has a number of obvious limitations. It was undertaken in a single province of a vast and extremely diverse country and 
the number of interviewees was relatively small. There is a clear need to replicate this work in other parts of China. However, the 
findings were discussed with participants at a national conference, eliciting a consensus that the findings were not atypical. 
 
The time required to conduct semi-structured interviews limited the numbers that could be included but also had numerous 
advantages. These included the ability to probe responses fully to clarify any ambiguities, to obtain information of greater depth, 
and to resolve misunderstandings, while ensuring a high response rate [29]. 
 
The findings are of considerable concern. They reveal widespread prescribing of unnecessary antibiotics, often administered 
parenterally. This is dangerous for two reasons. First, it encourages the development of antibiotic resistance, a phenomenon that, as 
we show, is imperfectly understood. Second, the use of injections and infusions poses a potential threat from spread of blood-borne 
viruses and infusion site infections. This study also sheds light on the reasons for this situation, including the existence of financial 
incentives and the limited availability of information on appropriate prescribing. The widespread use of anti-virals for self-limiting 
illness is especially striking, and is quite at variance with accepted practice elsewhere. 
 
A number of obvious implications flow from the findings. Bringing about behavioural change, especially when it is deeply 
entrenched, is never easy. However, some principles that should inform any policy can be discerned. First, there is a need for a 
multi-faceted strategy that encompasses education, regulation, and creation of incentives. Educational approaches should begin 
from what people already believe. As this study has shown, the concept of antibiotic resistance is known but imperfectly 
understood. An educational programme must begin by conveying knowledge that it is the micro-organism that develops resistance 
and not the patient. It should then convey at least a basic understanding of the evolutionary pressures that lead resistance to 
emerge. Learning should stress the need for sensitivity testing before switching antibiotics when treatment fails. Educational 
strategies could usefully be complemented by enhanced feedback, based on surveillance of emerging patterns of resistance, linked 
to guidance on the most appropriate antibiotics for each situation. Drug utilisation reviews in hospitals, as recommended by the 
WHO [30], can also play a part. China does have an essential drugs list but there is a need for greater awareness and use of it. 
 Yet education alone will not be enough, a view confirmed by an experience of applying Australian guidelines in Chinese hospitals 
[31]. As that study and ours found, there is a fundamental need to address the perverse economic incentives that encourage 
inappropriate prescribing. It is entirely understandable that physicians will overprescribe when they see this as the only way of 
ensuring the viability of their facilities. There is a need to abolish the 15% cap on profits that paradoxically increases both the 
unit price paid and volume of unnecessary antibiotics prescribed. Other areas demanding attention are the bonuses paid by 
pharmaceutical companies to hospitals and by hospitals to prescribers in return for meeting sales targets. 
 
Stepping back a little, it is apparent that the function identified by the WHO as stewardship, defined as the ‘the careful and 
responsible management of the well-being of the population’, is lacking [32]. This function resides in different places in health 
systems but those organisations that co-pay for care are well placed to exercise it. In China, the fragmentation of the insurance 
sector, with a multitude of small schemes, poses an obstacle to assuming this role. While it is not necessary to have structural 
consolidation of this sector (though this would be one solution, following the example of the Australian Pharmaceutical Benefits 
Scheme), more could be done through other mechanisms to collaborate in the development, implementation, and monitoring of 
evidence-based prescribing. What is important is that someone, somewhere, takes charge of addressing the quality of medicines 
provision. 
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